Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective
about
Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patientsReal-World Effectiveness and Safety of a Live-Attenuated Herpes Zoster Vaccine: A Comprehensive ReviewCytomegalovirus infection in the bone marrow transplant patientVaccination in patients with primary immune deficiency, secondary immune deficiency and autoimmunity with immune regulatory abnormalitiesBacterial Infections in Hematopoietic Stem Cell Transplant RecipientsPreventing stem cell transplantation-associated viral infections using T-cell therapyManagement of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignanciesBK virus-associated hemorrhagic cystitis after pediatric stem cell transplantationAntiviral T-cell therapyNorovirus gastroenteritis in immunocompromised patientsInfectious Complications after Umbilical Cord-Blood Transplantation from Unrelated DonorsHow I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipientsHepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-ScreenedReview: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients With Pulmonary InvolvementAntibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients.Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia.Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantationVaccination adherence in hematopoietic stem cell transplant patients: a pilot study on the impact of vaccination cards and reminder telephone calls.Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomesCan low-dose preemptive valganciclovir replace standard intravenous ganciclovir treatment in recipients of allogeneic stem cell transplantation?Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience.Late effects of blood and marrow transplantation.Varicella zoster virus infection after allogeneic hematopoietic cell transplantation in children using a relatively short duration of acyclovir prophylaxis: A retrospective study.Trends in Hospitalizations Related to Invasive Aspergillosis and Mucormycosis in the United States, 2000-2013.Invasive fungal infections in transplant recipientsImproving cellular therapy for primary immune deficiency diseases: recognition, diagnosis, and management.Current State of Antimicrobial Stewardship at Solid Organ and Hematopoietic Cell Transplant Centers in the United States.Duration of Antiviral Prophylaxis and Risk of Herpes Zoster among Patients Receiving Autologous Hematopoietic Stem Cell Transplants: A Retrospective, Observational StudyDetection of Herpesviridae in whole blood by multiplex PCR DNA-based microarray analysis after hematopoietic stem cell transplantation.Insufficient recovery of thymopoiesis predicts for opportunistic infections in allogeneic hematopoietic stem cell transplant recipients.Characterization of bacterial infections in allogeneic hematopoietic stem cell transplant recipients who received prophylactic levofloxacin with either penicillin or doxycycline.Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients.Impact of peri-transplant vancomycin and fluoroquinolone administration on rates of bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients: a 12-year single institution study.Facilitating surveillance of pulmonary invasive mold diseases in patients with haematological malignancies by screening computed tomography reports using natural language processing.Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.Bacterial foodborne infections after hematopoietic cell transplantationAllogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.
P2860
Q24193204-77700DC3-B0C7-4197-AC5C-9230CC8E095CQ26748712-15FD0F25-432A-410F-9C75-20F3DA3D9F7DQ26771385-BFBDA521-D15F-4AFE-9A7A-E91D7B1C8072Q26796420-0B0CE46D-BCEA-47E2-824B-9A9BC92558ECQ26799576-51B28E56-E4F6-45FC-BA32-30C00E1D7FE3Q26801365-73E83CFE-5388-4A78-B471-E47338CD0EC5Q26853131-C2B6EAD1-F129-4676-A719-B90B8230DE1DQ26859476-107F77F0-6075-460F-9DFF-A3833EF23052Q27028006-12CC4C26-518A-427C-AF86-FFA61B7F6EB6Q27694610-E603DD60-5E6D-44A5-8B82-B5AD1D8C6067Q28066500-390A122E-31CB-40BF-864B-4CE2D6E77A8EQ28069489-AE330CEE-BF50-4349-B151-47CF27E2E8F4Q28076703-6D82E939-E2A4-4314-849B-23595C79CFADQ28080076-9F3398EE-54B8-4A03-8C1E-A2F63F4D4AA6Q30238945-DDDB7BCF-D96D-4E4C-BEAA-70C24A0B8104Q30373149-1116326E-F19E-4075-9B71-841B98E398FCQ30390856-7E68898F-9E4F-49CD-AC23-B706F38C4991Q33400803-28AE99F0-A852-4118-8FE8-6900D9A16342Q33409354-BFE98E25-2090-461C-B049-C1DD434AE8D5Q33410539-BA9334DC-190C-4F99-BCF0-9BABE763E15DQ33410582-8A451AE4-A1AA-4231-9395-0A181C2460EDQ33559503-CA67E904-879F-4F33-A52C-8B30240D2B7AQ33566426-52E6FD18-2497-4E31-94B5-F7A34FAB0345Q33574136-CC712AE3-5C21-4B7C-BF69-BB65A6F3FC03Q33621313-C17323BA-BA36-4BF3-AFFD-DEAC1769EB09Q33629045-D741E2BB-3352-49EF-97FA-90E50BA94754Q33695215-DD541FB5-E6C2-47D4-8422-A283D0FBEB25Q33700953-27CFE5F2-7966-4584-BD4C-31F505982C43Q33782852-4B55FFD7-9497-41ED-9214-41809FF9CF0BQ33890886-B95BAC51-54B2-424B-8C95-C0D1B1D7E7F9Q33900083-F4F8379D-3DF9-4F4A-9052-EA0537BF808DQ34000647-11F99700-B795-47F6-BFC9-CAE91C0A39B0Q34030902-FBE1E37B-073C-4AD8-9B5F-0165C5B4CDBDQ34034462-FA82B85A-19A3-4EA3-A2B9-A2081FD60BAEQ34175284-4F361B62-2A2F-447C-B3C5-92D3E73F9E5BQ34245656-2D86A604-134B-4CE4-9F09-BE956956571EQ34273968-ABFAB808-DC3C-4CA1-8B7B-1B454A0E9FFAQ34325320-93FE330A-98B0-4FBE-B4E8-76D4E458E8D1Q34374139-94635C15-4C47-4188-A41F-C99255EB50A4Q34390072-399102EC-C9B4-4878-8918-75CBB49552A0
P2860
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Guidelines for preventing infe ...... cipients: a global perspective
@ast
Guidelines for preventing infe ...... cipients: a global perspective
@en
Guidelines for preventing infe ...... cipients: a global perspective
@nl
type
label
Guidelines for preventing infe ...... cipients: a global perspective
@ast
Guidelines for preventing infe ...... cipients: a global perspective
@en
Guidelines for preventing infe ...... cipients: a global perspective
@nl
prefLabel
Guidelines for preventing infe ...... cipients: a global perspective
@ast
Guidelines for preventing infe ...... cipients: a global perspective
@en
Guidelines for preventing infe ...... cipients: a global perspective
@nl
P2093
P2860
P3181
P1476
Guidelines for preventing infe ...... cipients: a global perspective
@en
P2093
Jan Storek
John R Wingard
Kent Sepkowitz
Marcie Tomblyn
Michael A Boeckh
Michael J Boeckh
Ronald Gress
Tom Chiller
P2860
P304
P3181
P356
10.1016/J.BBMT.2009.06.019
P407
P577
2009-10-01T00:00:00Z